X4 Pharmaceuticals, Inc. Financial Ratios — XFOR Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-90.37	-70.81	-61.51	-129.28	-135.58	-161.67	-102.26	-75.99
Return on Assets (%)	- -	-268.49	-76.25	-56.77	-53.69	-43.82	-73.9	-68.83	-66.81	-25.5	-36.25
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	100	- -	- -	- -	68.83	83.6
EBITDA Margin (%)	- -	- -	- -	- -	- -	-1,984.1	- -	- -	- -	-5,498.83	-243.8
Operating Margin (%)	- -	- -	- -	- -	- -	-1,995.8	- -	- -	- -	-5,529.96	-247.44
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	515.83	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-2,066.1	- -	- -	- -	-1,452.48	-225.44
Profit Margin (%)	- -	- -	- -	- -	- -	-2,071.03	- -	- -	- -	-1,464.61	-225.55
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-2,071.03	- -	- -	- -	-1,464.61	-225.55
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.14	- -	0.13	8.27	1.11	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-82.89	-70.03	-61.51	-129.28	-135.58	-161.67	-102.26	-75.99

Credit (USD)

Credit Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	7	15	12	8	23	38	40	38	58	78	77
ST Debt	2	5	2	- -	1	1	2	3	1	1	1
LT Debt	5	10	10	8	22	38	38	36	57	77	76
Total Debt/EBITDA	-0.59	-0.71	-0.38	-0.27	-0.48	-0.65	-0.53	-0.44	-0.54	-0.56	-0.9
Net Debt/EBITDA	-0.04	-0.57	2.01	0.79	2.22	0.76	0.64	1.01	0.42	-0.14	1.64
Total Debt/EBIT	-0.57	-0.7	-0.38	-0.27	-0.48	-0.64	-0.53	-0.44	-0.54	-0.55	-0.89
Net Debt/EBIT	-0.03	-0.56	2	0.79	2.22	0.76	0.64	1	0.42	-0.14	1.62
EBITDA to Interest Expense	-26.02	-8.62	-15.43	-40.25	-22.22	-22.14	-20.55	-21.93	-18.54	-16.04	-9.64
EBITDA-CapEx/Interest Expense	-26.38	-8.65	-15.45	-40.25	-22.3	-22.65	-20.72	-21.96	-18.55	-16.87	-9.98
EBIT to Interest Expense	-26.84	-8.73	-15.52	-40.4	-22.27	-22.27	-20.69	-22.06	-18.61	-16.13	-9.79
Interest Expense	- -	3	2	1	2	3	4	4	6	9	9
Common Equity/Total Assets	-360.9	-743.85	72.25	59.99	80.41	59.25	54.97	47.59	34.7	15.12	64.14
Long-Term Debt/Equity (%)	- -	- -	16.9	36.55	17.04	51.73	58.86	48.49	111.9	346.9	40.95
Long-Term Debt/Capital (%)	-17.34	-24.54	13.99	26.76	14.47	33.85	36.39	31.93	52.28	76.65	28.94
Long-Term Debt/Total Assets (%)	49.46	133.18	12.21	21.93	13.7	30.65	32.36	23.08	38.83	52.47	26.27
Total Debt/Equity (%)	-20.96	-27.03	20.84	36.55	17.73	52.81	61.77	51.88	114.06	352.55	41.49
Total Debt/Capital (%)	-26.52	-37.04	17.25	26.76	15.06	34.56	38.18	34.16	53.28	77.9	29.32
Total Debt/Total Assets (%)	75.65	201.07	15.06	21.93	14.26	31.29	33.95	24.69	39.58	53.32	26.61
Net Debt to Equity	-1.27	-21.66	-109.96	-105.83	-82.1	-62.54	-74.29	-118.97	-87.37	89.06	-75.56
Net Debt/Capital (%)	-1.28	-27.66	1,103.54	1,814.29	-408.83	-139.92	-213.53	952.73	-439.26	44.29	-302.54
EBITDA	-12	-22	-32	-29	-48	-60	-75	-88	-107	-141	-86
EBITDA-CapEx	-12	-22	-32	-29	-48	-61	-75	-88	-107	-148	-89
Operating Income (Loss)	-13	-22	-32	-29	-48	-60	-75	-88	-108	-141	-87

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.01	0.25	7.19	5.7	13.36	6.59	5.83	5.45	5	3.1	9.82
Current Ratio	1.26	0.47	7.45	6.5	13.68	6.97	6.27	5.76	5.34	3.41	10.16
Quick Ratio	1.24	0.36	7.34	6.23	13.57	6.66	5.89	5.5	5.02	3.16	9.84
CFO/Avg Current Liab	- -	-2.31	-2.45	-3.16	-6.47	-5.5	-5.46	-4.24	-4.27	-4.7	-2.92
Common Equity/Total Assets	-360.9	-743.85	72.25	59.99	80.41	59.25	54.97	47.59	34.7	15.12	64.14
Long-Term Debt/Equity (%)	- -	- -	16.9	36.55	17.04	51.73	58.86	48.49	111.9	346.9	40.95
Long-Term Debt/Capital (%)	-17.34	-24.54	13.99	26.76	14.47	33.85	36.39	31.93	52.28	76.65	28.94
Long-Term Debt/Total Assets (%)	49.46	133.18	12.21	21.93	13.7	30.65	32.36	23.08	38.83	52.47	26.27
Total Debt/Equity (%)	-20.96	-27.03	20.84	36.55	17.73	52.81	61.77	51.88	114.06	352.55	41.49
Total Debt/Capital (%)	-26.52	-37.04	17.25	26.76	15.06	34.56	38.18	34.16	53.28	77.9	29.32
Total Debt/Total Assets (%)	75.65	201.07	15.06	21.93	14.26	31.29	33.95	24.69	39.58	53.32	26.61
CFO/Total Liabilities	-24.68	-33.72	-123.61	-176.48	-152.66	-117.47	-134.38	-94.56	-100.37	-105.31	-82.19
CFO/CapEx	-63.62	-296.42	-663.6	- -	-276.18	-43.19	-115.29	-748.56	-1,608.53	-17.87	-28.54
Altman's Z-Score	-9.39	-21.28	2.97	-5.53	1.8	-2.72	-4.84	-4.11	-6.09	-8.55	-0.94

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.78	42.74
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	76.37	8.54
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.57	1.58
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	645.05	231.29
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.41	1.04
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	887.15	352.18
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	-165.73	-112.36
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	-568.68	-222.75
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	182	34	173	105	64	121	140	125	364
- Cash & Cash Equivalents	7	3	77	31	126	79	82	122	99	56	217
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	15	12	8	23	38	40	38	58	78	77
Enterprise Value	- -	12	118	11	69	65	22	38	84	101	188
Total Capital	-27	-41	71	29	152	111	104	112	109	100	264
Total Debt/Capital (%)	-26.52	-37.04	17.25	26.76	15.06	34.56	38.18	34.16	53.28	77.9	29.32
Total Debt / EV	16.54	1.25	0.1	0.72	0.33	0.6	1.78	1.02	0.69	0.77	0.41
EV/Sales	- -	- -	- -	- -	- -	21.53	- -	- -	- -	39.67	5.35
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	26	6	123	129	59	63	149	148	169
Diluted Enterprise Value	- -	12	-38	-16	20	89	17	-20	108	170	29
EV per Share	7.24	203.87	1,483.87	135.23	128.91	118.83	23.9	9.25	15.14	17.8	2.07
TTM Sales	- -	- -	- -	- -	- -	3	- -	- -	- -	3	35
TTM EBITDA	-12	-22	-32	-29	-48	-60	-75	-88	-107	-141	-86
TTM Operating Income	-13	-22	-32	-29	-48	-60	-75	-88	-108	-141	-87
TTM Cash Flow to Firm	-10	-19	-26	-25	-46	-56	-67	-73	-91	-122	-77
TTM Free Cash Flow to Firm	-10	-19	-26	-25	-46	-55	-67	-73	-91	-115	-74

Multiples (USD)

Valuation Multiples API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-0.95	-0.25	-2.58	-2.25	-0.84	-0.82	-1.55	-1.19	-2.05
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	12	118	11	69	65	22	38	84	101	188
Low Price	- -	- -	1,872	207	280.8	161.4	54	19.5	17.17	7.84	1.35
EV/Sales	- -	- -	- -	- -	- -	21.53	- -	- -	- -	39.67	5.35
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-0.85	-0.74	-3.25	-2.67	-1.94	-1	-2.18	-4.34	-3.16
Price/Earnings High	- -	- -	-1.2	-2.18	-5.17	-3.61	-3.11	-1.78	-4.53	-8.59	-13.05
Price/Earnings Low	- -	- -	-0.63	-0.09	-2.02	-1.74	-0.52	-0.44	-1.01	-1.4	-0.72
Price/Book Value	- -	- -	3.11	1.57	1.34	1.44	1	1.63	2.75	5.66	1.95
Price/Book Value Average	- -	- -	3.42	6.54	1.88	1.85	2.92	2.42	4.06	6.24	2.88
Price/Book Value High	- -	- -	4.8	19.36	2.99	2.5	4.67	4.32	8.45	12.35	11.93
Price/Book Value Low	- -	- -	2.53	0.78	1.17	1.21	0.79	1.07	1.88	2.02	0.66
Price/Tangible Book Value	- -	- -	3.11	1.57	1.69	2.29	1.37	2.13	4.16	-24.11	2.28
Price/Tangible Book Value Average	- -	- -	3.42	6.54	2.38	2.95	3.99	3.17	6.14	-26.57	3.36
Price/Tangible Book Value High	- -	- -	4.8	19.36	3.78	3.98	6.4	5.64	12.8	-52.58	13.91
Price/Tangible Book Value Low	- -	- -	2.53	0.78	1.48	1.92	1.08	1.39	2.84	-8.59	0.77
Price/Sales	- -	- -	- -	- -	- -	43.03	- -	- -	- -	57.69	4.82
Price/Sales Average	- -	- -	- -	- -	- -	55.33	- -	- -	- -	63.58	7.12
Price/Sales High	- -	- -	- -	- -	- -	74.69	- -	- -	- -	125.81	29.44
Price/Sales Low	- -	- -	- -	- -	- -	36	- -	- -	- -	20.55	1.63
Price/Cash Flow	- -	- -	-0.94	-0.25	-2.57	-2.19	-0.83	-0.82	-1.55	-1.13	-1.98
Price/Cash Flow Average	- -	- -	-1.04	-1.05	-3.62	-2.82	-2.43	-1.22	-2.28	-1.24	-2.92
Price/Cash Flow High	- -	- -	-1.46	-3.11	-5.74	-3.81	-3.89	-2.17	-4.75	-2.46	-12.07
Price/Cash Flow Low	- -	- -	-0.77	-0.12	-2.25	-1.84	-0.65	-0.54	-1.05	-0.4	-0.67
Price/Free Cash Flow Average	- -	- -	-1.04	-1.05	-3.63	-2.89	-2.45	-1.22	-2.28	-1.32	-3.03
Price/Free Cash Flow High	- -	- -	-1.46	-3.11	-5.76	-3.9	-3.92	-2.17	-4.76	-2.6	-12.51
Price/Free Cash Flow Low	- -	- -	-0.77	-0.12	-2.25	-1.88	-0.66	-0.54	-1.06	-0.43	-0.69
EV/Sales Average	- -	- -	- -	- -	- -	31.52	- -	- -	- -	62.82	11.32
EV/Sales High	- -	- -	- -	- -	- -	47.24	- -	- -	- -	115.72	59.29
EV/Sales Low	- -	- -	- -	- -	- -	15.82	- -	- -	- -	26.23	- -
EV/EBITDA Average	-0.04	-0.57	-4.25	-4.08	-2.93	-1.59	-1.95	-1.1	-1.55	-1.14	-4.64
EV/EBITDA High	-0.04	-0.57	-6.78	-13.64	-5.93	-2.38	-3.46	-2.7	-3.65	-2.1	-24.32
EV/EBITDA Low	-0.04	-0.57	-2.62	0.21	-1	-0.8	-0.12	0.05	-0.51	-0.48	0.2
EV/EBIT Average	-0.03	-0.56	-4.22	-4.07	-2.93	-1.58	-1.94	-1.09	-1.55	-1.14	-4.58
EV/EBIT High	-0.03	-0.56	-6.74	-13.59	-5.91	-2.37	-3.44	-2.69	-3.64	-2.09	-23.96
EV/EBIT Low	-0.03	-0.56	-2.61	0.21	-1	-0.79	-0.11	0.05	-0.51	-0.47	0.2
Last Price	- -	- -	2,296.8	417.6	321	192.9	68.7	29.79	25.16	22.01	4
High Price	- -	- -	3,550.8	5,164.8	717.9	334.8	321	78.9	77.4	48	24.44
Enterprise Value Average	- -	12	136	118	140	95	146	96	166	161	398
Enterprise Value High	- -	12	217	395	283	142	259	237	391	296	2,082
Enterprise Value Low	- -	12	84	-6	48	47	9	-4	55	67	-17

Shares Outstanding	- -	- -	- -	- -	1	1	1	4	6	6	91
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	2	6	7	42
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	2	6	7	42
Revenue per Share	- -	- -	- -	- -	- -	4.48	- -	- -	- -	0.38	0.83
EBITDA per Share	-397.02	-700.58	-2,799.9	-1,894.37	-124.11	-88.94	-87.21	-41.35	-18.07	-20.98	-2.02
Operating Income per Share	-409.59	-709.79	-2,816.92	-1,901.1	-124.38	-89.47	-87.79	-41.59	-18.14	-21.1	-2.05
Basic EPS, GAAP	-427.92	-742.73	-2,961.5	-2,371.72	-138.94	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Basic EPS from Cont Ops	-427.31	-742.73	-2,957.66	-2,175.63	-137.4	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Diluted EPS, GAAP	-427.92	-742.73	-2,961.5	-2,371.72	-138.94	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Diluted EPS from Cont Ops	-427.31	-742.73	-2,957.66	-2,175.63	-137.4	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-349.66	-699.54	-2,433.3	-1,661.55	-125.03	-87.89	-82.61	-36.41	-16.28	-19.53	-2.02
Free Cash Flow per Basic Share	-355.15	-701.9	-2,436.97	-1,661.55	-125.49	-89.92	-83.33	-36.46	-16.29	-20.62	-2.1
Cash & Equivalents per Share	112.45	50.49	967.01	379.88	234.71	144.81	87.23	30.01	20.46	17.91	2.78
Book Value per Share	-571.02	-941.02	739.26	266.81	240.35	133.94	68.7	18.26	9.16	3.89	2.05
Tangible Book Value per Share	-571.02	-941.02	739.26	266.81	189.93	84.06	50.19	13.98	6.05	-0.91	1.76

X4 Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)